Northwestern University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Northwestern University sits in the top decile of US sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count).

1,209 total trials 187 currently recruiting 767 completed early-phase tilt top decile by trial count

Northwestern University: 1,209 sponsored US clinical trials, 187 recruiting.

Northwestern University sponsors 1,209 registered US clinical trials on ClinicalTrials.gov, 187 of them currently recruiting, and 767 completed. 114 of these trials are in Phase 3-4 (later-stage) and 295 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 11 trials.

Top-decile sponsor footprint

Northwestern University ranks in the top decile of sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 50/100

767 of 912 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,209 total, page 14 of 25

COMPLETED Phase 2

MEDI4736 and Tremelimumab in Treating Patients With Metastatic HER2 Negative Breast Cancer

NCT02536794

COMPLETED NA

Telmisartan Plus Exercise to Improve Functioning in Peripheral Artery Disease

NCT02593110

COMPLETED NA

Technology Assisted Programs That Promote Mental Health for Teenagers

NCT01912729

COMPLETED NA

Trial of MRSA Polymerase Chain Reaction for Pneumonia

NCT02660554

COMPLETED NA

Healthy Hearts in the Heartland

NCT02598284

TERMINATED

Role Functioning Changes NOS

NCT02505022

COMPLETED

Iron Deficiency and FGF23 Regulation in CKD and HF

NCT03106298

COMPLETED NA

Online Peer Networked Collaborative Learning for Managing Depressive Symptoms

NCT02841787

TERMINATED NA

To Evaluate the Impact of SBI on C. Difficile in Hospitalized UC Patients

NCT02730325

COMPLETED Phase 4

Intra-articular Morphine and Clonidine Injections for Pain Management in Hip Arthroscopy

NCT02530151

COMPLETED

SUSTAIN-IT: Sustaining Quality of Life of the Aged: Heart Transplant or Mechanical Support?

NCT02568930

COMPLETED NA

Diagnostic Genicular Nerve Block Prior to Radiofrequency Ablation for Knee Osteoarthritis Pain

NCT02578108

COMPLETED Phase 2

Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy

NCT02314156

COMPLETED

Influenza Vaccine Responses as a Means of Assessing Immune Competence in Chimeric Kidney/Stem Cell Transplant Recipients

NCT02623075

TERMINATED NA

Determination of ED90 of Intrathecal Lidocaine for Adequate Anesthesia for Elective Cervical Cerclage Surgery

NCT02574832

TERMINATED Phase 1

Radiation Therapy With Temozolomide and Pembrolizumab in Treating Patients With Newly Diagnosed Glioblastoma

NCT02530502

COMPLETED Phase 4

Comparison of Low-dose and High-dose Oxytocin Regimens for Labor Augmentation

NCT02487797

COMPLETED NA

Training Primary Care Physicians to Perform Melanoma Opportunistic Surveillance

NCT02385253

COMPLETED NA

Evaluation of a Hospital Discharge Clinic to Improve Care Coordination and Reduce Rehospitalization in Low Income Adults

NCT03066492

TERMINATED Phase 2

Pidilizumab in Treating Patients With Stage III-IV Diffuse Large B-Cell Lymphoma Following First Remission

NCT02530125

COMPLETED NA

Fluid Immersion Simulation (FIS) System Versus Air Fluidized Bed (AFB) System for Pressure Ulcers

NCT03522714

COMPLETED NA

Parent Language Intervention for Autism

NCT02632773

COMPLETED Phase 2

Selective Intraoperative Administration of Local Anesthesia in Breast Reconstruction

NCT02525718

COMPLETED Phase 4

Behavioral Activation and Varenicline for Smoking Cessation in Depressed Smokers

NCT02378714

COMPLETED

Videocapillaroscopy Assessment During Systemic Agent Therapy in Psoriasis

NCT02162472

COMPLETED NA

EHR-Based Medication Complete Communication Strategy to Promote Safe Opioid Use

NCT02431793

COMPLETED NA

Auditory Stimulation of Slow Wave Sleep and Memory in Mild Cognitive Impairment and Older Adults

NCT02608840

COMPLETED NA

Variability In Hearing Aid Outcomes In Older Adults

NCT02448706

COMPLETED Phase 2

Stellate Ganglion Block (SGB) For Women for Breast Cancer

NCT02513329

TERMINATED

PAI-1 Expression in Non-scarring Hair Loss

NCT02548689

COMPLETED NA

Cutaneous Prostaglandin Application: Nail Growth, Nail Brittleness, and Eye Pressure

NCT02448043

COMPLETED

Cultural Differences in Treatment Preferences and Perceptions of Acne

NCT03192163

COMPLETED NA

Low InTensity Exercise Intervention in PAD

NCT02538900

COMPLETED Phase 3

A Trial of Cooled Radiofrequency Ablation of Medial Branch Nerves for theTreatment of Lumbar Facet Syndrome

NCT02478437

COMPLETED NA

Telemedicine for Women With Anhedonia in Bipolar and Unipolar Disorder

NCT02494050

COMPLETED NA

NUYou:mHealth Intervention to Preserve and Promote Ideal Cardiovascular Health

NCT02496728

COMPLETED

The Effect of Magnesium on Maternal Mood, Cognitive Function, and Birth Experience

NCT02454322

COMPLETED NA

Helping All Children be Safe Outdoors With Sun Protection

NCT02376517

COMPLETED NA

Melanoma Perception and Health Literacy in People of Color

NCT02437305

COMPLETED NA

Patient Centered Home Exercise Program for Peripheral Artery Disease

NCT02462824

COMPLETED

Lithium Therapy: Understanding Mothers, Metabolism and Mood

NCT02490241

COMPLETED Phase 4

The Effect of Intranasal Oxytocin on Pain Sensitivity and Threshold

NCT02550093

COMPLETED NA

A Research Study for Latina Women After Breast Cancer Treatment

NCT03645005

COMPLETED Phase 2

Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone Sarcomas

NCT02357810

TERMINATED Phase 1

Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML

NCT01849276

COMPLETED NA

IntelliCare: Artificial Intelligence in a Mobile Intervention for Depression and Anxiety (AIM)

NCT02176226

TERMINATED Early Phase 1

Molecular Effects of Topical Calcipotriene on Morphea

NCT02411643

COMPLETED Phase 4

Effect of L-dopa In Subacute Back Pain Population

NCT01951105

COMPLETED Phase 2

Prevention of Bone Loss After Acute SCI by Zoledronic Acid

NCT02325414

COMPLETED NA

Stepped Telemental Health Care Intervention for Depression

NCT01906476

← Previous Page 14 of 25 Next →

Phase Distribution

PhaseTrial count
Phase 1 132
Phase 2 163
Phase 3 36
Phase 4 78

What is open in the Northwestern University pipeline

187 recruiting of 1,209 indexed (15% open); 767 completed (63%).

Phase mix: 114 late (III/IV) vs 295 early (I/II) (early-phase heavy).

Top condition: Depression (11 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Northwestern University: open-pipeline peers nationwide

Peers matched on 1,209 registered trials and 15% open enrollment, not the therapeutic-area sidebar.

Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 12%14%16%18%20% Total trials Recruiting share Northwestern UniversityEmory UniversityUniversity of PittsburghNYU Langone HealthUniversity of Alabama at BirminghamBrigham and Women's HospitalIncyte CorporationNationwide Children's HospitalUniversity of Michigan Rogel Cancer Center
Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,209 trials (± recruiting share)

Sponsors near 15% open enrollment (± trial volume)

What to do with this Northwestern University page

1,209 registered trials is a research-attention snapshot, not an endorsement of Northwestern University or any single study.

  • 187 of Northwestern University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Depression is the condition Northwestern University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Northwestern University pipeline card: 1,209 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.